Introduction
Bronchiolitis is caused primarily by infection and inflammation of the smallest airways in the lungs, called the bronchioles. In most cases, the trigger is a viral infection, with respiratory syncytial virus (RSV) being the most common cause in infants and young children. The condition develops when a pathogen or other irritant injures the bronchiolar lining, leading to swelling, excess mucus production, and narrowing of the airway passages. These changes make it harder for air to move in and out of the lungs, especially during exhalation. Understanding bronchiolitis requires looking at both the direct biological trigger and the body’s inflammatory response that amplifies airway obstruction.
The causes of bronchiolitis can be grouped into several broad categories: infectious agents, especially viruses; host factors such as age and immune status; environmental exposures that make airway injury more likely; and underlying medical conditions that alter airway structure or defense mechanisms. Although the condition is often discussed as a single disease, it is better understood as a syndrome produced by a specific pattern of small-airway inflammation and blockage.
Biological Mechanisms Behind the Condition
The bronchioles are thin, branching airways that carry air from the larger bronchi to the alveoli, where gas exchange occurs. Under normal conditions, these airways remain open because their walls are lined with healthy epithelium, mucus is produced in limited amounts, and ciliary motion helps clear particles and microbes. The small caliber of these airways means that even modest swelling or mucus accumulation can have a large effect on airflow.
Bronchiolitis develops when the bronchiolar epithelium becomes infected or irritated. The injured cells release inflammatory signals that attract immune cells to the airway wall. This immune response causes edema, or tissue swelling, and increases mucus secretion. In addition, damaged ciliated cells are less able to move mucus upward and out of the lungs. The result is a combination of airway narrowing, mucus plugging, and impaired clearance of secretions.
In infants, the anatomy of the bronchioles makes these changes more consequential. Their airways are already narrow, so a small amount of swelling or debris can sharply increase resistance to airflow. Air trapping can occur when exhaled air cannot leave the lungs efficiently, which creates regions of overinflation and reduced ventilation. The physiologic problem is therefore not only infection, but the body’s inflammatory response to that infection and the mechanical effect of airway obstruction on ventilation.
Another important mechanism is epithelial injury. Many of the viruses associated with bronchiolitis attach to the surface of airway cells and replicate within them, leading to cell death and shedding of the lining. This exposes underlying tissue, intensifies inflammation, and further disrupts normal airway function. The combination of infection, immune activation, mucus overproduction, and epithelial damage explains why bronchiolitis can develop rapidly and why the small airways are especially vulnerable.
Primary Causes of Bronchiolitis
Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis. RSV infects the epithelial cells lining the bronchioles and triggers a strong local inflammatory response. The virus spreads efficiently through respiratory droplets and close contact, which is why it commonly affects infants and spreads in households, daycare settings, and seasonal outbreaks. RSV causes cell injury, mucus buildup, and swelling in the small airways, producing the classic pattern of bronchiolitis.
Other viral causes include rhinovirus, human metapneumovirus, parainfluenza virus, influenza virus, adenovirus, and coronavirus species. Although RSV remains the most common, these viruses can produce a similar final pathway of bronchiolar inflammation. Their shared effect is damage to the airway lining and activation of immune defenses that narrow the bronchioles. Different viruses vary in how strongly they inflame the airways, how much mucus they induce, and which age groups they affect most often.
Direct infection of the airway epithelium is the core cause across these viral illnesses. Once the pathogen enters the airway, it uses host cells to replicate. This replication injures cells and releases inflammatory mediators such as cytokines. These signals increase vascular permeability, draw fluid into the tissue, and recruit immune cells. The bronchiolar lumen becomes narrowed not just by the virus itself, but by the body’s attempt to eliminate it. In bronchiolitis, the defense response is a major part of the disease process.
In some cases, bronchiolitis can develop from less common infectious causes, including certain bacterial infections or atypical pathogens, although these are far less frequent as primary causes in typical infant bronchiolitis. When bacteria contribute, they generally do so by intensifying inflammation or causing secondary infection in airways already damaged by a viral illness. The biological pattern remains similar: airway inflammation, excess secretions, and impairment of small-airway airflow.
Contributing Risk Factors
Age is one of the most important risk factors. Infants, especially those under 12 months of age, are more susceptible because their airways are smaller, their immune responses are still developing, and their ability to clear secretions is limited. The same amount of swelling that would cause minor irritation in an older child can significantly obstruct airflow in an infant. Premature infants are at even greater risk because they may have underdeveloped lungs and less mature airway defenses.
Genetic influences can alter susceptibility by affecting immune regulation, airway structure, or inflammatory response. Some children inherit tendencies toward stronger or less well-controlled inflammatory reactions to viral infection. Others may have genetic variation that changes mucus production or interferon responses, making it harder to clear viruses efficiently. Genetic factors do not usually cause bronchiolitis by themselves, but they can shape how severely the airway reacts once infection begins.
Environmental exposures also matter. Tobacco smoke exposure is strongly associated with increased risk because it damages airway epithelium, impairs ciliary function, and increases baseline inflammation. Infants exposed to smoke may therefore have less effective airway defense and a more exaggerated inflammatory response to infection. Crowded living conditions, daycare attendance, and exposure to older siblings increase the chance of encountering respiratory viruses. Seasonal peaks in viral circulation, particularly in colder months, also increase exposure risk.
Feeding and social factors can contribute indirectly. Breastfeeding provides antibodies and other immune factors that can reduce the likelihood or severity of some respiratory infections, while lack of these protective factors may leave infants more vulnerable. Low socioeconomic conditions may increase exposure to pathogens through crowded housing and reduce access to preventive care, indirectly raising bronchiolitis risk. These are not direct biological causes, but they alter the probability that the infection and airway inflammation will occur.
Immune system differences are another important contributor. Infants and children with weaker antiviral defenses may clear respiratory viruses more slowly, allowing greater replication and more extensive epithelial damage. A delayed or poorly coordinated immune response can permit infection to spread farther into the lower airways. On the other hand, an overly intense inflammatory response can also worsen bronchiolar narrowing by causing more edema and mucus production. In bronchiolitis, both insufficient control of the virus and excessive inflammation can be harmful.
How Multiple Factors May Interact
Bronchiolitis usually develops through the interaction of several biological influences rather than a single isolated cause. A virus may infect the airway, but whether that infection becomes clinically significant depends on airway size, immune maturity, environmental exposures, and the intensity of inflammation. For example, an infant born prematurely may already have smaller or less resilient airways. If that infant is exposed to RSV in a household with tobacco smoke, the infected epithelium may be more easily damaged and the resulting inflammation may be more severe.
The interaction between infection and host response is central. The virus initiates the process by damaging the airway lining, but the immune system determines how much swelling, mucus production, and tissue injury occur afterward. In some children, the inflammatory response is efficient enough to limit infection without major obstruction. In others, the same infection creates a cascade of mucus plugging, epithelial sloughing, and bronchiolar narrowing. Environmental irritants can prime the airway to react more intensely, while underlying disease can reduce the lung’s capacity to compensate.
These interactions help explain why bronchiolitis can range from mild to severe even when the infecting virus is the same. The final clinical picture reflects the combined effects of pathogen, airway anatomy, immune function, and exposure history.
Variations in Causes Between Individuals
The cause of bronchiolitis may differ between individuals because the balance of risk factors is not the same in every person. In a healthy full-term infant with no smoke exposure, a viral infection may cause only limited bronchiolar inflammation. In a premature infant with smaller airways and less mature immunity, the same virus may produce substantial obstruction. Thus, the visible disease is shaped by both the microbe and the host.
Genetics can influence which viruses are more likely to cause lower respiratory tract disease and how strongly the airway responds. Some individuals have inherited immune patterns that lead to high levels of inflammatory signaling during infection, while others may have weaker antiviral defenses. These differences affect viral clearance and the extent of bronchiolar injury.
Age is especially important because the respiratory system changes rapidly during early childhood. Infants have narrower bronchioles, fewer reserves to compensate for obstruction, and less developed immune responses. Older children and adults may still become infected with the same viruses, but they are less likely to develop the same small-airway obstruction pattern that defines bronchiolitis.
Health status and exposure history also matter. Children with chronic lung disease, congenital heart disease, or repeated viral exposures may have different airway baseline conditions. Some have more reactive airways or impaired mucociliary clearance, making them more prone to bronchiolar inflammation. Living in a setting with frequent viral circulation, such as a large household or daycare, increases the chance that a person will encounter the relevant pathogens repeatedly.
Conditions or Disorders That Can Lead to Bronchiolitis
Several medical conditions can predispose a person to bronchiolitis by weakening the lungs’ defenses or making airway injury more likely. Prematurity is a major example. Premature infants often have smaller airways, less mature lungs, and less efficient immune defenses. These developmental limitations make it easier for viral infection to cause bronchiolar obstruction.
Chronic lung disease of prematurity, including bronchopulmonary dysplasia, can also increase susceptibility. In these children, airway structure and lung mechanics are already altered. When a viral infection occurs, the added inflammation and mucus production can more readily overwhelm the compromised airways.
Congenital heart disease may contribute indirectly by affecting pulmonary blood flow and overall physiologic reserve. Infants with these conditions may tolerate airway obstruction poorly and may have a harder time compensating for reduced ventilation. While the heart disease does not directly cause bronchiolitis, it can increase vulnerability to severe lower respiratory tract infection.
Immunodeficiency disorders are another important category. If the body cannot mount an effective antiviral response, respiratory viruses may replicate longer and spread more extensively through the lower airways. This prolongs epithelial injury and increases the degree of inflammation. Similarly, neuromuscular disorders that impair coughing and secretion clearance can promote mucus retention, which worsens bronchiolar obstruction once infection begins.
Structural airway abnormalities, such as congenital airway narrowing or other developmental differences, can also make the bronchioles more prone to blockage. In these cases, the same inflammatory swelling produces a greater physiologic effect because the airway starts from a narrower baseline.
Conclusion
Bronchiolitis develops when the smallest airways in the lungs become infected or irritated and respond with inflammation, swelling, mucus production, and impaired clearance of secretions. The most common cause is RSV, although other respiratory viruses can produce the same pattern of bronchiolar injury. The disease is driven not only by the infecting agent, but also by the body’s immune response, which can narrow the bronchioles enough to disrupt airflow.
Age, genetics, environmental exposures, and underlying medical conditions all influence how likely bronchiolitis is to develop and how severe it becomes. Prematurity, smoke exposure, immune immaturity, chronic lung disease, and certain heart or neuromuscular disorders can all increase susceptibility by weakening airway defenses or reducing the ability to compensate for obstruction. Looking at these mechanisms together provides a clearer explanation of why bronchiolitis occurs: it is the result of a vulnerable small-airway system meeting an infection or irritant that provokes disproportionate inflammation and mechanical blockage.